0001628280-22-018767.txt : 20220711 0001628280-22-018767.hdr.sgml : 20220711 20220711061631 ACCESSION NUMBER: 0001628280-22-018767 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220518 FILED AS OF DATE: 20220711 DATE AS OF CHANGE: 20220711 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jayne David R.W. CENTRAL INDEX KEY: 0001838242 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36421 FILM NUMBER: 221075840 MAIL ADDRESS: STREET 1: #1203-4464 MARKHAM STREET CITY: VICTORIA STATE: A1 ZIP: BC V8Z7X8 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aurinia Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001600620 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: #1203-4464 MARKHAM STREET CITY: VICTORIA BC STATE: A1 ZIP: V8Z 7X8 BUSINESS PHONE: 250-708-4272 MAIL ADDRESS: STREET 1: #1203-4464 MARKHAM STREET CITY: VICTORIA BC STATE: A1 ZIP: V8Z 7X8 4/A 1 wf-form4a_165753457810786.xml FORM 4/A X0306 4/A 2022-05-18 2022-05-20 0 0001600620 Aurinia Pharmaceuticals Inc. AUPH 0001838242 Jayne David R.W. #1203-4464 MARKHAM STREET VICTORIA A1 V8Z7X8 BRITISH COLUMBIA, CANADA 1 0 0 0 Common Stock 2022-05-18 4 M 0 10000 3.62 A 40000 D Stock Option (right to buy) 3.62 2022-05-18 4 M 0 10000 0 D 2027-02-16 Common Stock 10000.0 0 D Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date. The shares subject to the option are fully vested and immediately exercisable. They vested in twelve equal monthly installments from the grant date. This amendment is filed to correct the inadvertent omission of the option exercise transaction from the Reporting Person's Form 4 filed on May 20, 2022. /s/ David R.W. Jayne, M.D. 2022-07-08